You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

squamous

Showing 26 - 50 of 7,403
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Minimal Residual Disease, Esophageal Squamous Cell Carcinoma Trial in Guangzhou

Not yet recruiting
  • Minimal Residual Disease
  • Esophageal Squamous Cell Carcinoma
    • Guangzhou, Guangdong, China
      Guangdong Provincial People's Hospital
    Jun 10, 2023

    Esophageal Squamous Cell Carcinoma Trial (XH-30002 capsule, Afatiinb tablet)

    Not yet recruiting
    • Esophageal Squamous Cell Carcinoma
    • XH-30002 capsule
    • Afatiinb tablet
    • (no location specified)
    Jun 25, 2023

    Head and Neck Squamous-cell Carcinoma

    Not yet recruiting
    • Squamous Cell Carcinoma of Head and Neck
    • +2 more
      • (no location specified)
      Nov 5, 2023

      Squamous Cell Carcinoma of Head and Neck, Hypopharyngeal Squamous Cell Carcinoma, Laryngeal Squamous Cell Carcinoma Stage III

      Not yet recruiting
      • Squamous Cell Carcinoma of Head and Neck
      • +11 more
      • KEYTRUDA®
      • (no location specified)
      Nov 17, 2023

      Head and Neck Squamous Cell Carcinoma, Radiotherapy, Radiosensitizer Trial in China (Pirfenidone, Placebo)

      Recruiting
      • Head and Neck Squamous Cell Carcinoma
      • +3 more
      • Guangzhou, Guangdong, China
      • +4 more
      Nov 16, 2023

      Esophageal Squamous Cell Carcinoma, Neoadjuvant Chemoimmunotherapy, Adjuvant Therapy Trial in Shanghai (Tislelizumab)

      Recruiting
      • Esophageal Squamous Cell Carcinoma
      • +2 more
      • Shanghai, Shanghai, China
        Shanghai chest hospital
      Sep 24, 2023

      Esophageal Squamous Cell Carcinoma Trial in Shanghai (Tirelizumab, Nab paclitaxel, Carboplatin)

      Recruiting
      • Esophageal Squamous Cell Carcinoma
      • Shanghai, Shanghai, China
        Ruijin hospital, Shanghai jiaotong university school of medicine
      Nov 6, 2023

      Cutaneous Squamous Cell Carcinoma, Cutaneous Squamous Cell Carcinoma of the Head and Neck, Tumors Trial in Melbourne

      Not yet recruiting
      • Cutaneous Squamous Cell Carcinoma
      • +3 more
      • Melbourne, Victoria, Australia
        Peter MacCallum Cancer Centre
      May 17, 2023

      Esophageal Squamous Cell Carcinoma Trial (LY01015, Fluorouracil, Cisplatin)

      Not yet recruiting
      • Esophageal Squamous Cell Carcinoma
      • (no location specified)
      Aug 28, 2023

      Head and Neck Squamous Cell Carcinoma, PET/CT Trial (Neck dissection)

      Not yet recruiting
      • Head and Neck Squamous Cell Carcinoma
      • PET/CT
      • Neck dissection
      • (no location specified)
      Jan 31, 2023

      Esophageal Squamous Cell Carcinoma, Esophageal Cancer, Metastatic Esophageal Squamous Cell Carcinoma Trial in Shanghai

      Recruiting
      • Esophageal Squamous Cell Carcinoma
      • +2 more
      • LDRT+CFRT
      • +2 more
      • Shanghai, China
      • +1 more
      Aug 3, 2023

      Squamous Cell Carcinoma of the Oral Cavity or Oropharynx Trial (Black Raspberry)

      Not yet recruiting
      • Squamous Cell Carcinoma of the Oral Cavity or Oropharynx
      • Black Raspberry
      • (no location specified)
      Oct 16, 2023

      Salivary LINC00657 asDiagnostic Biomarker for Oral Squamous Cell

      Completed
      • Oral Squamous Cell Carcinoma
        • Fayoum, Egypt
          faculty of dentistry, Fayoum university
        Apr 19, 2023

        Esophageal Squamous Cell Carcinoma Trial in Shantou (Tislelizumab)

        Recruiting
        • Esophageal Squamous Cell Carcinoma
        • Shantou, Guangdong, China
          Cancer Hospital of Shantou University Medical College
        Aug 2, 2023

        Esophageal Squamous Cell Carcinoma by AJCC V8 Stage Trial (Radiotherapy, Toripalimab)

        Not yet recruiting
        • Esophageal Squamous Cell Carcinoma by AJCC V8 Stage
        • (no location specified)
        Mar 17, 2023

        Squamous Cell Carcinoma of the Skin Trial in Zhengzhou (Carrilizumab with albumin-binding paclitaxel)

        Not yet recruiting
        • Squamous Cell Carcinoma of the Skin
        • Carrilizumab with albumin-binding paclitaxel
        • Zhengzhou, Henan, China
          Henan Cancer Hospital
        May 23, 2023

        Advanced Lung Squamous Cell Carcinoma

        Not yet recruiting
        • Advanced Lung Squamous Cell Carcinoma
        • No treatment is included in this study
        • Changsha, Hunan, China
          Yongchang Zhang
        Aug 11, 2023

        Head and Neck Squamous Cell Carcinoma Trial in Guangzhou (Nab paclitaxel, Carboplatin, adelbelimumab)

        Not yet recruiting
        • Head and Neck Squamous Cell Carcinoma
        • Nab paclitaxel
        • +2 more
        • Guangzhou, Guangdong, China
          Sun Yat-sen Memorial Hospital
        Aug 24, 2023

        Oral Squamous Cell Carcinoma Trial (Three-Week Treatment Regimen with Trastuzumab in Combination with Docetaxel and Platinum

        Not yet recruiting
        • Oral Squamous Cell Carcinoma
        • Three-Week Treatment Regimen with Trastuzumab in Combination with Docetaxel and Platinum Triple Therapy
        • (no location specified)
        Nov 11, 2023

        Head and Neck Squamous Cell Carcinoma, Locally Advanced Operable Trial in Guangzhou (Cadonilimab, Docetaxel, Cisplatin)

        Recruiting
        • Head and Neck Squamous Cell Carcinoma
        • Locally Advanced Operable
        • Guangzhou, Guangdong, China
        • +1 more
        Sep 4, 2023

        Esophageal Cancer Trial in Wuhan

        Recruiting
        • Esophageal Cancer
          • Wuhan, Hubei, China
            Renmin hosptial of Wuhan University
          Jun 7, 2023

          Esophageal Squamous Cell Carcinoma Trial in Wuhan (Intensity-modulated radiotherapy (IMRT), Tislelizumab, Cisplatin)

          Not yet recruiting
          • Esophageal Squamous Cell Carcinoma
          • Intensity-modulated radiotherapy (IMRT)
          • +3 more
          • Wuhan, Hubei, China
            Renmin hosptial of Wuhan University
          Jun 16, 2023

          People Living With HIV, Oral and Oropharyngeal Cancer, and

          Not yet recruiting
          • HIV Infections
          • +2 more
          • Group Meeting (Focus Group)
          • Questionnaires
          • San Francisco, California
            University of California, San Francisco
          Sep 20, 2023

          Head and Neck Squamous Cell Carcinoma, Head Neck Cancer Trial (Tislelizumab, BGB-A425, LBL-007)

          Not yet recruiting
          • Head and Neck Squamous Cell Carcinoma
          • Head and Neck Cancer
          • (no location specified)
          Jun 9, 2023

          Esophageal Squamous Cell Carcinoma (ESCC), PD-1 Inhibitors Trial in Zhengzhou (IBI110+Sintilimab)

          Not yet recruiting
          • Esophageal Squamous Cell Carcinoma (ESCC)
          • PD-1 Inhibitors
          • Zhengzhou, Henan, China
            Feng Wang
          Oct 9, 2023